Form D · Biotechnology

ALIGN TECHNOLOGY INC

Santa Clara, CA · CIK 0001097149

Offering snapshot reported Aug 31, 2009 · SEC filing

Reported sold
$72.3M
Offering amount: $98.6M
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Aug 16, 2009
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 31, 2009Initial$72,299,357No comparison1SEC filing

Offering details

Securities
Not reported
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-50741
Securities were issued in consideration for settlement of litigation involving the issuer and recipient. Issuer received no cash proceeds in connection with issuance. Amounts above calculated based on closing price of issuer's common stock on 08/17/09.

Source: Form D, filed Aug 31, 2009. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Kenneth B Arola Executive
Dana C Cambra Executive
David E Collins Director
Dan S Ellis Executive
Roger E George Executive
Len Hedge Executive
Joseph Lacob Director
Gil Laks Executive
C Raymond Larkin Jr Director
George J Morrow Director
David Nagel Director
Thomas M Prescott Director, Executive
Greg J Santora Director
Sheila Tan Executive
Warren S Thaler Director
Emory Wright Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
851 Martin Avenue
Santa Clara, CA, 95050